NYXH
OtherNyxoah SA
$3.22+0.25 (+8.42%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving NYXH Today?
No stock-specific AI insight has been generated for NYXH yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$141M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume25K
Avg Volume (10D)—
Shares Outstanding43.7M
NYXH News
20 articles- Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026Yahoo Finance·May 8, 2026
- Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseYahoo Finance·May 5, 2026
- How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed TargetsYahoo Finance·May 5, 2026
- Nyxoah to Participate in the Bank of America 2026 Healthcare ConferenceYahoo Finance·Apr 30, 2026
- Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026Yahoo Finance·Apr 28, 2026
- Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87Yahoo Finance·Apr 4, 2026
- Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026Marketbeat·Mar 21, 2026
- Publication relating to transparency notificationsYahoo Finance·Mar 20, 2026
- Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial ChallengesYahoo Finance·Mar 20, 2026
- Nyxoah (NYXH) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 19, 2026
- Nyxoah Q4 Earnings Call HighlightsMarketbeat·Mar 19, 2026
- Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 19, 2026
- Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsYahoo Finance·Mar 19, 2026
- Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 ResultYahoo Finance·Mar 18, 2026
- Publication relating to transparency notificationYahoo Finance·Mar 13, 2026
- KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 12, 2026
- Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceYahoo Finance·Mar 11, 2026
- Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026Yahoo Finance·Mar 5, 2026
- Information on the total number of voting rights and sharesYahoo Finance·Feb 25, 2026
- How The Nyxoah (ENXTBR:NYXH) Story Is Shifting As Assumptions And Risks Are ReworkedYahoo Finance·Feb 23, 2026
All 20 articles loaded
Price Data
Open$0.00
Previous Close$2.97
Day High$0.00
Day Low$0.00
52 Week High—
52 Week Low—
Fundamentals
Market Cap$141M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume25K
Avg Volume (10D)—
Shares Outstanding43.7M
About Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—